Access Statistics for Anirban Basu

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Choosing Wisely: Evaluating Latent Factor Models in the Presence of a Contaminated Instrumental Variable with Varying Strength 0 0 1 1 3 7 31 31
Comparing 2SLS vs 2SRI for Binary Outcomes and Binary Exposures 0 0 2 48 10 22 35 116
Do For-Profit Hospitals Cream-Skim Patients? Evidence from Inpatient Psychiatric Care in California 0 0 4 14 1 3 13 27
Dynamic Efficiency and Pricing of Innovations with Insurance: The Case for Gene Therapies 0 0 0 5 3 8 9 23
Economics of Individualization in Comparative Effectiveness Research and a Basis for a Patient-Centered Health Care 0 1 1 48 8 16 20 194
Estimating Lifetime or Episode-of-illness Costs 0 1 1 109 4 6 8 293
Estimating Person-Centered Treatment (PeT) Effects Using Instrumental Variables 0 0 0 52 2 2 3 157
Exploring comparative effect heterogeneity with instrumental variables: prehospital intubation and mortality 0 0 0 18 3 7 10 107
Exploring comparative effect heterogeneity with instrumental variables: prehospital intubation and mortality 0 0 0 39 1 3 11 195
Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data 1 1 1 47 3 5 6 166
Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data 0 0 0 290 2 7 7 879
Hidden Figures: Uncovering Quantities Behind Zeros with Econometrics 0 0 0 16 2 2 3 24
Impact of Rural and Urban Hospital Closures on Inpatient Mortality 0 0 0 86 9 10 16 168
Political Polarization, Anticipated Health Insurance Uptake and Individual Mandate: A view from the Washington State 0 0 0 16 1 2 2 39
Price Elasticities of Pharmaceuticals in a Value-Based-Formulary Setting 0 1 1 63 4 9 15 108
Returns to Pharmaceutical Innovation in the Market for Oral Chemotherapy in Response to Insurance Coverage Expansion 0 0 0 50 3 5 6 40
Service-level Selection: Strategic Risk Selection in Medicare Advantage in Response to Risk Adjustment 0 0 0 7 5 22 23 73
The Impact of Comparative Effectiveness Research on Health and Health Care Spending 0 0 0 57 4 5 6 234
The New Prescription Drug Paradox: Pipeline Pressure and Rising Prices 0 0 0 73 0 3 7 109
The Role of Physician Altruism in the Physician-Industry Relationship: Evidence from Linking Experimental and Observational Data 1 1 12 12 1 8 24 24
The Roles of Cognitive and Non-Cognitive Skills in Moderating the Effects of Mixed-Ability Schools on Long-Term Health 0 0 0 42 1 2 2 103
The impact of Medicare Part D on Medicare-Medicaid Dual-eligible Beneficiaries' Prescription Utilization and Expenditures 0 0 0 42 3 6 11 170
Understanding Algorithmic Discrimination in Health Economics Through the Lens of Measurement Errors 0 0 0 21 4 8 8 58
Use of Propensity Scores in Non-Linear Response Models: The Case for Health Care Expenditures 0 0 0 54 3 4 5 223
Use of instrumental variables in the presence of heterogeneity and self-selection: An application in breast cancer patients 0 0 1 484 4 7 14 1,353
Use of propensity scores in non-linear response models: The case for health care expenditures 0 0 1 147 4 5 13 530
Welfare Implications of Learning Through Solicitation versus Diversification in Health Care 0 0 0 36 4 6 7 62
Total Working Papers 2 5 25 1,877 92 190 315 5,506


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
CAN WE MAKE SMART CHOICES BETWEEN OLS AND CONTAMINATED IV METHODS? 0 0 0 3 3 4 5 29
Comparing alternative models: log vs Cox proportional hazard? 0 0 1 148 3 5 8 577
Does Competition under Medicare Prospective Payment Selectively Reduce Expenditures on High-Cost Patients? 0 0 0 0 2 6 11 324
ESTIMATING PERSON‐CENTERED TREATMENT (PeT) EFFECTS USING INSTRUMENTAL VARIABLES: AN APPLICATION TO EVALUATING PROSTATE CANCER TREATMENTS 0 0 0 6 1 4 11 50
Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care 0 0 0 29 4 6 12 255
Erratum: Estimating lifetime or episode‐of‐illness costs under censoring 0 0 0 15 2 3 5 51
Estimating lifetime or episode‐of‐illness costs under censoring 1 2 3 23 5 11 17 95
Extended generalized linear models: Simultaneous estimation of flexible link and variance functions 0 0 1 145 2 3 7 424
Generalized modeling approaches to risk adjustment of skewed outcomes data 0 0 0 143 2 3 5 362
HETEROGENEITY IN ACTION: THE ROLE OF PASSIVE PERSONALIZATION IN COMPARATIVE EFFECTIVENESS RESEARCH 0 0 0 2 3 5 6 30
HIGHLIGHTING DIFFERENCES BETWEEN CONDITIONAL AND UNCONDITIONAL QUANTILE REGRESSION APPROACHES THROUGH AN APPLICATION TO ASSESS MEDICATION ADHERENCE 0 0 1 105 5 10 12 299
Implications of spillover effects within the family for medical cost-effectiveness analysis 0 0 0 72 2 8 14 198
Measuring the Value of Pharmaceuticals in the US Health System 0 0 0 5 0 0 0 14
Person-centered treatment (PeT) effects: Individualized treatment effects using instrumental variables 0 1 2 40 0 3 7 156
Personalized Medicine in the Context of Comparative Effectiveness Research 0 0 0 13 3 5 5 107
Private Manufacturers’ Thresholds to Invest in Comparative Effectiveness Trials 0 0 0 5 2 4 4 51
RESPONSE TO EPSTEIN'S COMMENT ON “HETEROGENEITY IN ACTION” 0 0 0 1 2 2 2 20
Scale of interest versus scale of estimation: comparing alternative estimators for the incremental costs of a comorbidity 0 0 0 52 3 3 3 220
The impact of comparative effectiveness research on health and health care spending 0 0 0 35 4 5 7 281
Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modeling 0 4 11 932 8 34 70 2,765
Welfare implications of learning through solicitation versus diversification in health care 0 0 0 2 3 4 6 40
Total Journal Articles 1 7 19 1,776 59 128 217 6,348


Software Item File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
IVCHECK: Stata module to choose between OLS and contaminated IV 0 0 4 28 3 6 19 250
Total Software Items 0 0 4 28 3 6 19 250


Statistics updated 2026-02-12